Addus HomeCare's (ADUS) Outperform Rating Reaffirmed at Macquarie

Addus HomeCare (NASDAQ:ADUS - Get Free Report)'s stock had its "outperform" rating reiterated by investment analysts at Macquarie in a report issued on Tuesday,Benzinga reports. They presently have a $133.00 price objective on the stock. Macquarie's price target would indicate a potential upside of 14.74% from the company's current price.

Other equities research analysts also recently issued reports about the stock. Wall Street Zen downgraded shares of Addus HomeCare from a "buy" rating to a "hold" rating in a research note on Wednesday, February 26th. Stephens reaffirmed an "overweight" rating and set a $142.00 price target on shares of Addus HomeCare in a research report on Wednesday, March 12th. Finally, JMP Securities reissued a "market outperform" rating and issued a $150.00 price objective on shares of Addus HomeCare in a research report on Tuesday, April 22nd. One investment analyst has rated the stock with a hold rating, six have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Buy" and an average price target of $142.57.

Addus HomeCare Price Performance

ADUS stock traded down $2.09 on Tuesday, hitting $115.91. 122,481 shares of the company were exchanged, compared to its average volume of 169,122. The stock has a market capitalization of $2.13 billion, a price-to-earnings ratio of 26.51, a price-to-earnings-growth ratio of 1.41 and a beta of 0.81. Addus HomeCare has a twelve month low of $88.96 and a twelve month high of $136.72. The business's fifty day moving average is $106.56 and its two-hundred day moving average is $112.38.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its quarterly earnings data on Monday, May 5th. The company reported $1.42 EPS for the quarter, topping analysts' consensus estimates of $1.33 by $0.09. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The business had revenue of $337.71 million during the quarter, compared to the consensus estimate of $341.66 million. During the same period in the prior year, the firm posted $1.21 EPS. The business's revenue for the quarter was up 20.3% on a year-over-year basis. Equities research analysts expect that Addus HomeCare will post 4.59 earnings per share for the current year.

Insider Activity at Addus HomeCare

In other news, EVP Michael D. Wattenbarger sold 2,045 shares of the company's stock in a transaction on Tuesday, May 27th. The stock was sold at an average price of $115.00, for a total transaction of $235,175.00. Following the completion of the sale, the executive vice president now directly owns 7,796 shares of the company's stock, valued at $896,540. This represents a 20.78% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 4.60% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Addus HomeCare

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Amundi increased its holdings in Addus HomeCare by 185.9% in the 4th quarter. Amundi now owns 9,008 shares of the company's stock valued at $1,139,000 after buying an additional 5,857 shares during the period. King Luther Capital Management Corp acquired a new position in shares of Addus HomeCare in the 4th quarter worth approximately $4,223,000. Victory Capital Management Inc. raised its holdings in shares of Addus HomeCare by 14.0% in the 4th quarter. Victory Capital Management Inc. now owns 96,832 shares of the company's stock worth $12,138,000 after buying an additional 11,872 shares in the last quarter. Envestnet Asset Management Inc. lifted its position in shares of Addus HomeCare by 9.4% during the 4th quarter. Envestnet Asset Management Inc. now owns 42,698 shares of the company's stock worth $5,352,000 after buying an additional 3,659 shares during the period. Finally, Equitable Trust Co. boosted its stake in Addus HomeCare by 47.1% in the 4th quarter. Equitable Trust Co. now owns 7,096 shares of the company's stock valued at $889,000 after buying an additional 2,271 shares in the last quarter. Institutional investors and hedge funds own 95.35% of the company's stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.